NEW YORK — The maker of the powerful painkiller OxyContin said it will stop marketing opioid drugs to doctors, bowing to a key demand of lawsuits that blame the company for helping trigger the current drug abuse epidemic. OxyContin has long been the world’s top-selling opioid painkiller, bringing in billions in sales for privately-held Purdue, which also sells a newer and longer-lasting opioid drug called Hysingla. The company announced its surprise reversal on Saturday.
JERUSALEM — The chief executive of Teva Pharmaceuticals on Thursday said he is making “strong progress” on the company’s restructuring plan, even as the company posted a huge loss and forecast a challenging 2018. In an interview, CEO Kare Schultz said he remained confident about the company’s long-term prospects, laying out a two-year turnaround timeline and predicting a “clear move upward” in 2020. The restructuring has marked a stunning setback in